Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.

Título

Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.

Autor

C Trojaniello, M G Vitale, P A Ascierto

Fecha

2021

Identificador

10.1016/j.annonc.2021.02.008

Fuente

Annals of oncology : official journal of the European Society for Medical Oncology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/8a66ff2f6418eaa3f902cb761518a97a.pdf

Colección

Coronavirus

Citación

C Trojaniello, M G Vitale, P A Ascierto, “Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.,” SOCICT Open, consulta 22 de abril de 2026, https://socictopen.socict.org/items/show/8754.

Formatos de Salida

Position: 11182 (24 views)